Log in

Alzheimer's Research & Prevention Foundation

Working Towards Prevention Since 1993

The New Covid-Alzheimer’s Connection

  • 8 Dec 2022
  • 4:00 PM - 5:00 PM (PST)

Registration


Register


The Covid pandemic has struck particularly hard at older Americans, with most of the deaths from Covid-19 concentrated in those over 65 years of age, especially if they have co-morbid conditions. Many of the risk factors for acquisition and severity of SARS-CoV2 are also risk factors for Alzheimer’s disease (AD).

In this program, we will discuss the bi-directional relationships between Covid and AD, including the susceptibility, outcomes and disparities of Covid associated with AD during the early phase of the pandemic, the risk of breakthrough infection and associated outcomes following vaccination against SARS-CoV2, and the risk of new diagnosis of AD in the year following infection with SARS-CoV2.  

SARS-CoV2 infection may itself produce symptoms in the central nervous system, both in the acute infection phase, and in the longer term sequelae that have been called “long Covid”. These long Covid symptoms include “brain fog” or cognitive impairment. However, long Covid is incompletely understood, and its degree of permanence is uncertain. Besides the direct effect of SARS-CoV2 infection on the brain, the infection may also trigger or unmask other brain disorders.

Our work identified an association between SARS-CoV2 infection and new diagnoses of AD in the following year. This program will discuss that finding and how it might be interpreted, as well as the necessary studies to follow up this observation.  


The New Covid-Alzheimer's Connection
Thursday, December 8th, 2022
4 pm PT / 5 pm MT / 6 pm CT / 7 pm ET
Duration: 60 minutes
Guest Speakers: Pamela B. Davis, MD, PhD and Rong Xu, PhD, FACMI
Host: Christopher Walling, PSY.D, MBA, C-IAYT, SEP

Please join us on Thursday, December 8th for this exceptional discussion on how Covid affects cognition.

You will also receive the recording after.  


Learning Objectives:

  • Identify important risk factors for the development of Alzheimer’s disease
  • Discuss the risk for SARS-CoV2 infection in patients with Alzheimer’s disease
  • Describe the association between Covid and the development of Alzheimer’s disease
  • Discuss the negative cognitive effects of Covid
  • Discuss potential treatments of long Covid in patients with Alzheimer’s disease

The New Covid-Alzheimer's Connection
Thursday, December 8th, 2022
4 pm PT / 5 pm MT / 6 pm CT / 7 pm ET
Duration: 60 minutes
Guest Speakers: Pamela B. Davis, MD, PhD and Rong Xu, PhD, FACMI
Hosts: Christopher Walling, PSY.D, MBA, C-IAYT, SEP


About the Speakers:

Pamela B. Davis, MD, PhD

Arline H. and Curtis F. Garvin Research Professor and Professor, Center for Community Health Integration, Distinguished University Professor, Case Western Reserve University School of Medicine

Following a 30-year career as a physician-scientist working in cystic fibrosis, Pamela B. Davis, MD, PhD, became dean of the School of Medicine and senior vice president for medical affairs at Case Western Reserve University in 2007. She stepped down in 2020 to begin a new research career in bioinformatics. During her time as dean she was an active supporter of the new Western Reserve 2 medical school curriculum, improved the commercialization of research discoveries in the School, and greatly expanded activities in support of the health of the community.  She served for two cycles as the principal investigator of the NIH’s CTSA award, and has championed the discipline of broadly engaged team science. During her career, Davis has been inducted into the National Academy of Medicine and the National Academy of Inventors, served on the Advisory Councils of NIDDK and NCATS and the Board of Scientific Counselors of NHLBI. 


Rong Xu, PhD, FACMI

Professor of Biomedical Informatics, Director of Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine

Dr. Xu earned her BS degree in Biology from Peking University, M.S degree in Biology from Case Western Reserve University, M.S in Computer Science and Ph.D. in Biomedical Informatics both from Stanford University. Dr. Xu’s research falls into two broad categories: theoretical computer algorithm development and translational biomedical research. Her research interests in computer science focus on artificial intelligence, natural language processing, machine learning, data mining, statistical learning, systems biology, and other advanced computational techniques that can create, integrate, and analyze large amounts of heterogeneous and complex biological and health data. Her research interests in biomedical sciences include drug discovery, disease gene discovery, precision medicine, and health outcomes research. Dr. Xu has received several prestigious awards: (1) elected Fellow of American College of Medical Informatics; (2) The NIH Director’s New Innovator Award, (3) the Landon-AACR (American Association for Cancer Research) Innovator Award for Cancer Prevention Research, (4) the AMIA (American Medical Informatics Association) New Investigator award. Her research works in COVID-19 in vulnerable population including patients with Alzheimer’s disease have been included in the CDC guidelines, reached tens of millions of twitters, and featured in > 1000 news including New York Times, NPR, ABC news, NBC news, Forbes, USA Today, Fox News and Scientific Americans.


Christopher Walling, PSY.D, MBA, C-IAYT, SEP

Adjunct Professor, Somatic Psychology, California Institute for Integral Studies, San Francisco, CA, USA

Dr. Walling is a licensed clinical psychologist, researcher and an active leader in the biobehavioral sciences. His work in academic medicine has included the administration of multidisciplinary leadership teams in hematology-oncology, physical medicine and rehabilitation, and geriatric psychiatry at some of the top academic medical centers in the United States. His clinical focus in the behavioral sciences has examined the intersections of neuro-psychotherapy, affect regulation, and psychophysiology. Dr. Walling is an Adjunct Professor of Somatic Psychology at the California Institute of Integral Studies, Past-President of the United States Association for Body Psychotherapy, and an Associate Deputy-Editor of the International Body Psychotherapy Journal. He is a Clinical Supervisor at the Wright Institute of Los Angeles, a Clinical Associate at the New Center for Psychoanalysis, and is a Clinical Research Fellow at the Traumatic Stress Research Consortium located at Indiana University where he and his colleagues are working to advance scientific insights from trauma psychology. Dr. Walling maintains a private practice in Los Angeles, California.


Can’t attend in person? No problem. This webinar will be recorded and sent to you a few days later. The link for Zoom video access will be sent out in the confirmation email after registration is completed.

Important: Please add admin@arpf.com to your contact list so no communication gets lost in spam.

This webinar is part of ARPF's fundraising initiative. Your registration fee supports programs of ARPF.  We thank you for supporting our mission.

We also accept PayPal. Please contact Chelsea to make arrangements chelsea@alzheimersprevention.org

Alzheimer's Research & Prevention Foundation

Chelsea@alzheimersprevention.org
Phone (888) 908-5766
Fax (520) 838-9855

PO Box 30783 
Tucson, AZ 85751-0783

© 2022 Alzheimer’s Research and Prevention Foundation.


The Alzheimer's Research and Prevention Foundation is a leading global Alzheimer's disease (AD) prevention organization, funding more Alzheimer's prevention integrative medicine research than any other non-profit, while providing educational outreach to laypeople, healthcare providers and caregivers on the 4 Pillars of Alzheimer's Prevention.

ARPF is a charitable organization registered in AZ, CA, CT, FL, IL, MD, MA, MO, MI, NJ, NM, NY, OH, NC, PA, RI, TX, VA, WA, WI. In FL, ARPF's registration number is CH-31726 under s.496.411(3), F.S..


Privacy Policy and Important Notice:

ARPF does not provide medical advice nor promote any product or service. The contents are for informational purposes only and are not intended as a substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on this web site. The ARPF, its affiliates or agents, or any other parties involved in the preparation or publication of this site are not responsible for errors or omissions in information provided on this site or any actions resulting from the use of such information.


Powered by Wild Apricot